However, apatinib with immunotherapy resulted in a slight increase in the incidence of some apatinib-related adverse events or serious adverse events, including hypertension and elevated alanine transaminase (ALT) and aspartate transaminase (AST) levels. Here, GPT is linked to hypertensive disorder.